Tech Company Financing Transactions
Synuca Therapeutics Funding Round
Synuca Therapeutics secured a $49 million funding round on 3/3/2026. Investors included Lundbeckfonden BioCapital.
Transaction Overview
Company Name
Announced On
3/3/2026
Transaction Type
Venture Equity
Amount
$49,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Ole Maaløes Vej 3
Copenhagen, 2200
Denmark
Copenhagen, 2200
Denmark
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
SynuCa Therapeutics combines decades of groundbreaking research in P-type ATPases and neuroscience from Aarhus University to propose a novel disease-modifying treatment for patients suffering from Parkinson's Disease and associated disorders. By targeting the SERCA calcium transporter, our first-in-class small molecules salvage the root disease cause by repairing the neuronal calcium imbalances caused by pathological a-Synuclein brain species.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lasse Reimer
Browse more venture capital transactions:
Prev: 3/3/2026: Jovian Concepts venture capital transaction
Next: 3/3/2026: JetStream Security venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs